News & Events
LEO Pharma Completes Peplin Acquisition; Peplin to Continue as an Independent Subsidiary
12 / 11 / 2009
ChemGenex Announces FDA Accepts NDA for Omaproâ?¢ (Omacetaxine Mepesuccinate) and Grants the Filing Priority Review Status
10 / 11 / 2009
WOMENâ??S SEXUAL HEALTH COMPANY CHANGES NAME IN PREPARATION FOR MARKET ENTRY TivaMed Becomes Viveve
09 / 11 / 2009
Sunshine Heart - C-Pulse US Clinical Update Highlights Well Being of Four Initial Clinical Trial Patients
21 / 09 / 2009
ChemGenex Submits New Drug Application for OMAPROâ?¢ (Omacetaxine Mepesuccinate) to U.S. FDA
09 / 09 / 2009
Novasys - Renessa® Treatment for Female Incontinence Gets Expanded Medicare Coverage
01 / 09 / 2009
Verva Announces License of Key FGFR Intellectual Property to Isis Pharmaceuticals, Inc. for the Treatment of Obesity and Other Diseases
20 / 08 / 2009
Sunshine Heart - $1.75 million Placement completed, $8.1 million Rights Issue announced
10 / 08 / 2009
Xenome and Axxam initiate discovery partnership focused on novel peptides against GPCR targets
05 / 08 / 2009
NUON THERAPEUTICS INC. APPOINTS PAULETTE DILLON, CHIEF BUSINESS OFFICER, AND TITO SERAFINI, CHIEF SCIENTIFIC OFFICER
09 / 07 / 2009
Displaying records 451-475 of 705